In addition to ATOX1, investigation of the potential of other copper transporters and chaperones in siRNA therapy of NSCLC and other cancers, such as ATP7B in ovarian cancer (28) and ATP7A in neuroblastoma (29) is warranted. This evidence concerns the gene ATP7B and ovarian carcinoma.